Summary: Many pharmaceutical companies are getting out of Alzheimer’s research because they aren’t finding that “silver bullet” treatment to cure the disease. However, perhaps we should instead be looking for the “silver buckshot” treatment, because it is only by addressing many smaller areas of concern that you effectively reduce your risk for Alzheimer’s Disease. In this epsidode with Dr. David Perlmutter, Dr. Daniel Amen and Tana Amen discuss some of these “silver buckshot” elements.
